Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grabowski

Showing results (121-130 of 259) with videos related to

Pageof 26
Sort By:
Molecular Genetics and Metabolism|January 25, 2011
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse modelsY H Xu, Y Sun, H Ran, et al.
Plos One|October 8, 2009
In vivo and ex vivo evaluation of L-type calcium channel blockers on acid beta-glucosidase in Gaucher disease mouse modelsYing Sun, Benjamin Liou, Brian Quinn, et al.
American Heart Journal|December 1, 1980
The M-mode echocardiogram in Fabry's diseaseJ L Bass, S Shrivastava, G A Grabowski, et al.
Progress in Clinical and Biological Research|January 1, 1982
Gaucher disease: a membranous enzymopathyR J Desnick, G A Grabowski, T Dinur, et al.
Metabolism: Clinical and Experimental|March 1, 1988
Abnormalities in lipoprotein metabolism in Gaucher type 1 diseaseN A Le, J C Gibson, A Rubinstein, et al.
The Journal of Biological Chemistry|January 21, 1994
Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expressionM E Grace, K M Newman, V Scheinker, et al.
Biochemistry|May 13, 1999
Conformational and amino acid residue requirements for the saposin C neuritogenic effectX Qi, K Kondoh, D Krusling, et al.
Molecular Genetics and Metabolism|March 19, 2008
Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levelsYou-Hai Xu, Rachel Reboulet, Brian Quinn, et al.
The American Journal of Medicine|September 1, 1984
Immune thrombocytopenia and Gaucher's diseaseT J Lester, G A Grabowski, J Goldblatt, et al.
Human Mutation|January 1, 1996
Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populationsJ W Kim, B B Liou, M Y Lai, et al.
Pageof 26

Showing results (121-130 of 259) with videos related to

Sort By:
Pageof 26
Molecular Genetics and Metabolism|January 25, 2011
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse modelsY H Xu, Y Sun, H Ran, et al.
Plos One|October 8, 2009
In vivo and ex vivo evaluation of L-type calcium channel blockers on acid beta-glucosidase in Gaucher disease mouse modelsYing Sun, Benjamin Liou, Brian Quinn, et al.
American Heart Journal|December 1, 1980
The M-mode echocardiogram in Fabry's diseaseJ L Bass, S Shrivastava, G A Grabowski, et al.
Progress in Clinical and Biological Research|January 1, 1982
Gaucher disease: a membranous enzymopathyR J Desnick, G A Grabowski, T Dinur, et al.
Metabolism: Clinical and Experimental|March 1, 1988
Abnormalities in lipoprotein metabolism in Gaucher type 1 diseaseN A Le, J C Gibson, A Rubinstein, et al.
The Journal of Biological Chemistry|January 21, 1994
Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expressionM E Grace, K M Newman, V Scheinker, et al.
Biochemistry|May 13, 1999
Conformational and amino acid residue requirements for the saposin C neuritogenic effectX Qi, K Kondoh, D Krusling, et al.
Molecular Genetics and Metabolism|March 19, 2008
Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levelsYou-Hai Xu, Rachel Reboulet, Brian Quinn, et al.
The American Journal of Medicine|September 1, 1984
Immune thrombocytopenia and Gaucher's diseaseT J Lester, G A Grabowski, J Goldblatt, et al.
Human Mutation|January 1, 1996
Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populationsJ W Kim, B B Liou, M Y Lai, et al.
Pageof 26